ChromaDex: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
ChromaDex (NASDAQ:CDXC) reported its Q3 earnings, beating estimated earnings by 66.67% with an EPS of $-0.01 versus an estimate of $-0.03. Revenue was up $2.43 million from the same period last year. Last quarter, the company beat on EPS by $0.01, which was followed by a 2.42% drop in the share price the next day.
November 08, 2023 | 9:50 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
ChromaDex's Q3 earnings beat estimates, but past performance shows a share price drop following an EPS beat. Investors should monitor the stock closely.
ChromaDex's Q3 earnings beat estimates, which is generally a positive signal. However, the company's share price dropped after a similar EPS beat last quarter. This suggests that despite the positive earnings news, the market may not react positively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100